LJ

Linc Johnson

Chief Scientific Officer

Regenerative Patch Technologies

Regenerative Patch Technologies Pipeline

DrugIndicationPhase
CPCB-RPE1 ImplantAdvanced Dry Age-Related Macular Degeneration (Geographic Atrophy)Phase 2b

Leadership Team at Regenerative Patch Technologies

View full Regenerative Patch Technologies profile